Negative Group N = 123 (72.8%) | Positive Group N = 46 (27.2%) | t-Test p value | |
---|---|---|---|
Female Age (in years) | 34.94 ± 4.03 (19–39) | 34.28 ± 3.35 (25–39) | 0.290 |
Male Age (in years) | 36.14 ± 4.76 (22–46) | 37.19 ± 5.91 (29–62) | 0.832 |
Time of Infertility (in months) | 54.46 ± 33.82 (12–204) | 60.22 ± 38.49 (14–192) | 0.375 |
Type of Infertility: | |||
• Primary | 95/123 (77.2%) | 38/46 (82.6%) | 0.297 |
• Secondary | 28/123 (22.8%) | 8/46 (17.4%) | |
Male Associated Infertility | 28.2% | 31.1% | 0.654 |
Body Mass Index (Kg/cm2) | 25.8 ± 3.2 | 26.1 ± 3.4 | 0.765 |
Antimullerian hormone (pg/mL) | 2.45 ± 2.45 (0.09–16.65) | 2.62 ± 2.46 (0.04–13.56) | 0.679 |
Antral follicle count | 8.43 ± 5.07 (2–40) | 8.63 ± 3.74 (2–20) | 0.801 |
Total dose of gonadotropins (in International Units) | 2500.81 ± 812.19 (300–4500) | 2508.15 ± 757.91 (450–4500) | 0.956 |
Progesterone levels at Trigger day (ng/mL) | 0.88 ± 0.44 (0.01–2.20) | 0.78 ± 0.47 (0.01–2.10) | 0.188 |
Number of collected Oocytes | 8.25 ± 5.14 (2–22) | 10.50 ± 5.20 (2–23) | 0.140 |
Metaphase II Oocytes | 6.57 ± 4.22 (2–17) | 7.06 ± 4.77 (2–21) | 0.150 |
Number of day 3 embryos | 3.18 ± 2.40 (2–12) | 3.84 ± 2.65 (2–12) | 0.120 |
Number of blastocysts for vitrification | 0.65 ± 1.51 (0–6) | 0.86 ± 1.71 (0–9) | 0.200 |